nodes	percent_of_prediction	percent_of_DWPC	metapath
Olanzapine—ALB—multiple sclerosis	0.209	1	CbGaD
Olanzapine—CYP2D6—Fingolimod—multiple sclerosis	0.0411	0.11	CbGbCtD
Olanzapine—ALB—Prednisone—multiple sclerosis	0.0325	0.0873	CbGbCtD
Olanzapine—ABCB1—Methylprednisolone—multiple sclerosis	0.0281	0.0754	CbGbCtD
Olanzapine—CYP3A4—Fingolimod—multiple sclerosis	0.0261	0.0701	CbGbCtD
Olanzapine—HTR1B—trigeminal nucleus—multiple sclerosis	0.0224	0.109	CbGeAlD
Olanzapine—HTR1D—trigeminal nucleus—multiple sclerosis	0.0217	0.106	CbGeAlD
Olanzapine—CYP2C19—Prednisone—multiple sclerosis	0.0211	0.0566	CbGbCtD
Olanzapine—ABCB1—Mitoxantrone—multiple sclerosis	0.0205	0.055	CbGbCtD
Olanzapine—HTR3A—area postrema—multiple sclerosis	0.0197	0.0962	CbGeAlD
Olanzapine—ABCB1—Betamethasone—multiple sclerosis	0.0183	0.049	CbGbCtD
Olanzapine—ABCB1—Prednisolone—multiple sclerosis	0.018	0.0484	CbGbCtD
Olanzapine—ABCB1—Prednisone—multiple sclerosis	0.017	0.0457	CbGbCtD
Olanzapine—CYP3A4—Methylprednisolone—multiple sclerosis	0.0168	0.0452	CbGbCtD
Olanzapine—ALB—Methotrexate—multiple sclerosis	0.0163	0.0438	CbGbCtD
Olanzapine—HTR1D—meninx—multiple sclerosis	0.0144	0.0704	CbGeAlD
Olanzapine—CYP2C19—Dexamethasone—multiple sclerosis	0.0132	0.0353	CbGbCtD
Olanzapine—CYP3A4—Triamcinolone—multiple sclerosis	0.0127	0.0342	CbGbCtD
Olanzapine—CYP3A4—Mitoxantrone—multiple sclerosis	0.0123	0.033	CbGbCtD
Olanzapine—CYP2C9—Dexamethasone—multiple sclerosis	0.0109	0.0294	CbGbCtD
Olanzapine—CYP3A4—Betamethasone—multiple sclerosis	0.0109	0.0294	CbGbCtD
Olanzapine—CYP3A4—Prednisolone—multiple sclerosis	0.0108	0.029	CbGbCtD
Olanzapine—HTR2A—trigeminal nucleus—multiple sclerosis	0.0108	0.0526	CbGeAlD
Olanzapine—ABCB1—Dexamethasone—multiple sclerosis	0.0106	0.0285	CbGbCtD
Olanzapine—CYP3A4—Prednisone—multiple sclerosis	0.0102	0.0274	CbGbCtD
Olanzapine—CYP2D6—Dexamethasone—multiple sclerosis	0.01	0.0269	CbGbCtD
Olanzapine—ABCB1—Methotrexate—multiple sclerosis	0.00853	0.0229	CbGbCtD
Olanzapine—CYP3A4—Dexamethasone—multiple sclerosis	0.00636	0.0171	CbGbCtD
Olanzapine—HTR1B—trigeminal nerve—multiple sclerosis	0.00588	0.0288	CbGeAlD
Olanzapine—HTR1D—trigeminal nerve—multiple sclerosis	0.00569	0.0278	CbGeAlD
Olanzapine—HTR7—pons—multiple sclerosis	0.00319	0.0156	CbGeAlD
Olanzapine—HTR2A—trigeminal nerve—multiple sclerosis	0.00283	0.0138	CbGeAlD
Olanzapine—DRD1—nerve—multiple sclerosis	0.00265	0.013	CbGeAlD
Olanzapine—HTR3A—nerve—multiple sclerosis	0.00256	0.0125	CbGeAlD
Olanzapine—HTR5A—nervous system—multiple sclerosis	0.00239	0.0117	CbGeAlD
Olanzapine—HTR5A—central nervous system—multiple sclerosis	0.0023	0.0113	CbGeAlD
Olanzapine—HTR7—peripheral nervous system—multiple sclerosis	0.00212	0.0104	CbGeAlD
Olanzapine—HTR2A—pons—multiple sclerosis	0.00199	0.00974	CbGeAlD
Olanzapine—HTR1E—brainstem—multiple sclerosis	0.00195	0.00953	CbGeAlD
Olanzapine—HTR5A—brain—multiple sclerosis	0.00183	0.00894	CbGeAlD
Olanzapine—HTR7—nerve—multiple sclerosis	0.00165	0.0081	CbGeAlD
Olanzapine—DRD2—nerve—multiple sclerosis	0.00156	0.00766	CbGeAlD
Olanzapine—ADRA2A—peripheral nervous system—multiple sclerosis	0.00156	0.00762	CbGeAlD
Olanzapine—HTR2A—pineal body—multiple sclerosis	0.00142	0.00695	CbGeAlD
Olanzapine—HTR2A—peripheral nervous system—multiple sclerosis	0.00132	0.00648	CbGeAlD
Olanzapine—DRD1—brainstem—multiple sclerosis	0.00114	0.00556	CbGeAlD
Olanzapine—H1F0—retina—multiple sclerosis	0.00111	0.00543	CbGeAlD
Olanzapine—HTR3A—brainstem—multiple sclerosis	0.0011	0.00537	CbGeAlD
Olanzapine—HTR2A—nerve—multiple sclerosis	0.00103	0.00505	CbGeAlD
Olanzapine—HTR1E—nervous system—multiple sclerosis	0.00102	0.00499	CbGeAlD
Olanzapine—HTR1E—central nervous system—multiple sclerosis	0.000982	0.00481	CbGeAlD
Olanzapine—HTR1B—brainstem—multiple sclerosis	0.000921	0.00451	CbGeAlD
Olanzapine—DRD4—brain—multiple sclerosis	0.000904	0.00443	CbGeAlD
Olanzapine—CHRM4—nervous system—multiple sclerosis	0.000895	0.00438	CbGeAlD
Olanzapine—HTR1D—brainstem—multiple sclerosis	0.000892	0.00436	CbGeAlD
Olanzapine—HTR2C—brainstem—multiple sclerosis	0.000883	0.00432	CbGeAlD
Olanzapine—CHRM4—central nervous system—multiple sclerosis	0.000861	0.00422	CbGeAlD
Olanzapine—DRD3—nervous system—multiple sclerosis	0.000832	0.00407	CbGeAlD
Olanzapine—FMO3—nervous system—multiple sclerosis	0.000822	0.00402	CbGeAlD
Olanzapine—H1F0—medulla oblongata—multiple sclerosis	0.000803	0.00393	CbGeAlD
Olanzapine—DRD3—central nervous system—multiple sclerosis	0.000801	0.00392	CbGeAlD
Olanzapine—HTR6—nervous system—multiple sclerosis	0.000801	0.00392	CbGeAlD
Olanzapine—FMO3—central nervous system—multiple sclerosis	0.000792	0.00387	CbGeAlD
Olanzapine—HTR1E—brain—multiple sclerosis	0.00078	0.00382	CbGeAlD
Olanzapine—DRD5—nervous system—multiple sclerosis	0.000779	0.00381	CbGeAlD
Olanzapine—HTR6—central nervous system—multiple sclerosis	0.000771	0.00377	CbGeAlD
Olanzapine—DRD5—central nervous system—multiple sclerosis	0.00075	0.00367	CbGeAlD
Olanzapine—HTR1A—brainstem—multiple sclerosis	0.000743	0.00364	CbGeAlD
Olanzapine—H1F0—midbrain—multiple sclerosis	0.000734	0.00359	CbGeAlD
Olanzapine—HRH2—nervous system—multiple sclerosis	0.000732	0.00358	CbGeAlD
Olanzapine—DRD1—midbrain—multiple sclerosis	0.000724	0.00355	CbGeAlD
Olanzapine—H1F0—spinal cord—multiple sclerosis	0.000716	0.0035	CbGeAlD
Olanzapine—HTR7—brainstem—multiple sclerosis	0.00071	0.00348	CbGeAlD
Olanzapine—HRH2—central nervous system—multiple sclerosis	0.000705	0.00345	CbGeAlD
Olanzapine—CHRM5—nervous system—multiple sclerosis	0.000699	0.00342	CbGeAlD
Olanzapine—ADRA1A—brainstem—multiple sclerosis	0.000685	0.00335	CbGeAlD
Olanzapine—CHRM4—brain—multiple sclerosis	0.000684	0.00335	CbGeAlD
Olanzapine—CHRM5—central nervous system—multiple sclerosis	0.000673	0.00329	CbGeAlD
Olanzapine—DRD2—brainstem—multiple sclerosis	0.000672	0.00329	CbGeAlD
Olanzapine—DRD2—retina—multiple sclerosis	0.000648	0.00317	CbGeAlD
Olanzapine—ADRA1B—nervous system—multiple sclerosis	0.000639	0.00313	CbGeAlD
Olanzapine—DRD3—brain—multiple sclerosis	0.000636	0.00311	CbGeAlD
Olanzapine—FMO3—brain—multiple sclerosis	0.000629	0.00308	CbGeAlD
Olanzapine—HTR2C—medulla oblongata—multiple sclerosis	0.000616	0.00301	CbGeAlD
Olanzapine—ADRA1B—central nervous system—multiple sclerosis	0.000615	0.00301	CbGeAlD
Olanzapine—HTR6—brain—multiple sclerosis	0.000612	0.00299	CbGeAlD
Olanzapine—ORM1—spinal cord—multiple sclerosis	0.000611	0.00299	CbGeAlD
Olanzapine—H1F0—nervous system—multiple sclerosis	0.000603	0.00295	CbGeAlD
Olanzapine—DRD5—brain—multiple sclerosis	0.000596	0.00292	CbGeAlD
Olanzapine—DRD1—nervous system—multiple sclerosis	0.000596	0.00291	CbGeAlD
Olanzapine—HTR1B—midbrain—multiple sclerosis	0.000587	0.00287	CbGeAlD
Olanzapine—H1F0—central nervous system—multiple sclerosis	0.000581	0.00284	CbGeAlD
Olanzapine—HTR3A—nervous system—multiple sclerosis	0.000575	0.00281	CbGeAlD
Olanzapine—DRD1—central nervous system—multiple sclerosis	0.000573	0.00281	CbGeAlD
Olanzapine—HTR1B—spinal cord—multiple sclerosis	0.000573	0.0028	CbGeAlD
Olanzapine—HTR1D—midbrain—multiple sclerosis	0.000568	0.00278	CbGeAlD
Olanzapine—H1F0—cerebellum—multiple sclerosis	0.000568	0.00278	CbGeAlD
Olanzapine—HTR2C—midbrain—multiple sclerosis	0.000563	0.00275	CbGeAlD
Olanzapine—HRH2—brain—multiple sclerosis	0.000559	0.00274	CbGeAlD
Olanzapine—HTR3A—central nervous system—multiple sclerosis	0.000554	0.00271	CbGeAlD
Olanzapine—HTR2C—spinal cord—multiple sclerosis	0.000549	0.00269	CbGeAlD
Olanzapine—CHRM5—brain—multiple sclerosis	0.000534	0.00262	CbGeAlD
Olanzapine—ORM1—nervous system—multiple sclerosis	0.000515	0.00252	CbGeAlD
Olanzapine—ORM1—central nervous system—multiple sclerosis	0.000496	0.00243	CbGeAlD
Olanzapine—HTR7—medulla oblongata—multiple sclerosis	0.000495	0.00242	CbGeAlD
Olanzapine—ADRA1B—brain—multiple sclerosis	0.000488	0.00239	CbGeAlD
Olanzapine—HTR1B—nervous system—multiple sclerosis	0.000483	0.00236	CbGeAlD
Olanzapine—CHRM2—nervous system—multiple sclerosis	0.00048	0.00235	CbGeAlD
Olanzapine—HTR1A—midbrain—multiple sclerosis	0.000474	0.00232	CbGeAlD
Olanzapine—HTR1D—nervous system—multiple sclerosis	0.000467	0.00229	CbGeAlD
Olanzapine—HTR1B—central nervous system—multiple sclerosis	0.000465	0.00227	CbGeAlD
Olanzapine—HTR2C—nervous system—multiple sclerosis	0.000463	0.00226	CbGeAlD
Olanzapine—HTR1A—spinal cord—multiple sclerosis	0.000462	0.00226	CbGeAlD
Olanzapine—CHRM2—central nervous system—multiple sclerosis	0.000462	0.00226	CbGeAlD
Olanzapine—H1F0—brain—multiple sclerosis	0.000461	0.00226	CbGeAlD
Olanzapine—ADRA2C—medulla oblongata—multiple sclerosis	0.000455	0.00223	CbGeAlD
Olanzapine—DRD1—brain—multiple sclerosis	0.000455	0.00223	CbGeAlD
Olanzapine—HTR7—midbrain—multiple sclerosis	0.000453	0.00222	CbGeAlD
Olanzapine—HTR1D—central nervous system—multiple sclerosis	0.00045	0.0022	CbGeAlD
Olanzapine—HTR2C—central nervous system—multiple sclerosis	0.000445	0.00218	CbGeAlD
Olanzapine—HTR2A—brainstem—multiple sclerosis	0.000443	0.00217	CbGeAlD
Olanzapine—HTR7—spinal cord—multiple sclerosis	0.000442	0.00216	CbGeAlD
Olanzapine—HTR3A—brain—multiple sclerosis	0.00044	0.00215	CbGeAlD
Olanzapine—CHRM1—nervous system—multiple sclerosis	0.000437	0.00214	CbGeAlD
Olanzapine—HTR2B—nervous system—multiple sclerosis	0.000435	0.00213	CbGeAlD
Olanzapine—DRD2—midbrain—multiple sclerosis	0.000428	0.00209	CbGeAlD
Olanzapine—HTR2A—retina—multiple sclerosis	0.000427	0.00209	CbGeAlD
Olanzapine—CHRM1—central nervous system—multiple sclerosis	0.000421	0.00206	CbGeAlD
Olanzapine—HTR2B—central nervous system—multiple sclerosis	0.000418	0.00205	CbGeAlD
Olanzapine—ADRA2C—midbrain—multiple sclerosis	0.000416	0.00204	CbGeAlD
Olanzapine—ADRA2C—spinal cord—multiple sclerosis	0.000406	0.00199	CbGeAlD
Olanzapine—CYP2D6—brainstem—multiple sclerosis	0.000404	0.00197	CbGeAlD
Olanzapine—CHRM3—nervous system—multiple sclerosis	0.000391	0.00191	CbGeAlD
Olanzapine—HTR1A—nervous system—multiple sclerosis	0.000389	0.00191	CbGeAlD
Olanzapine—CHRM3—central nervous system—multiple sclerosis	0.000376	0.00184	CbGeAlD
Olanzapine—HTR1A—central nervous system—multiple sclerosis	0.000375	0.00183	CbGeAlD
Olanzapine—HTR7—nervous system—multiple sclerosis	0.000372	0.00182	CbGeAlD
Olanzapine—HTR1B—brain—multiple sclerosis	0.000369	0.00181	CbGeAlD
Olanzapine—CHRM2—brain—multiple sclerosis	0.000367	0.0018	CbGeAlD
Olanzapine—HTR1A—cerebellum—multiple sclerosis	0.000366	0.00179	CbGeAlD
Olanzapine—ADRA2A—medulla oblongata—multiple sclerosis	0.000363	0.00178	CbGeAlD
Olanzapine—ADRA1A—nervous system—multiple sclerosis	0.000359	0.00176	CbGeAlD
Olanzapine—HTR7—central nervous system—multiple sclerosis	0.000358	0.00175	CbGeAlD
Olanzapine—HTR1D—brain—multiple sclerosis	0.000357	0.00175	CbGeAlD
Olanzapine—HTR2C—brain—multiple sclerosis	0.000354	0.00173	CbGeAlD
Olanzapine—DRD2—nervous system—multiple sclerosis	0.000352	0.00172	CbGeAlD
Olanzapine—HTR7—cerebellum—multiple sclerosis	0.00035	0.00171	CbGeAlD
Olanzapine—ADRA1A—central nervous system—multiple sclerosis	0.000346	0.00169	CbGeAlD
Olanzapine—ALB—brain—multiple sclerosis	0.000345	0.00169	CbGeAlD
Olanzapine—ADRA2C—nervous system—multiple sclerosis	0.000342	0.00167	CbGeAlD
Olanzapine—DRD2—central nervous system—multiple sclerosis	0.000339	0.00166	CbGeAlD
Olanzapine—ADRA1A—cerebellum—multiple sclerosis	0.000338	0.00165	CbGeAlD
Olanzapine—CHRM1—brain—multiple sclerosis	0.000334	0.00163	CbGeAlD
Olanzapine—HTR2B—brain—multiple sclerosis	0.000332	0.00163	CbGeAlD
Olanzapine—ADRA2A—midbrain—multiple sclerosis	0.000332	0.00162	CbGeAlD
Olanzapine—DRD2—cerebellum—multiple sclerosis	0.000331	0.00162	CbGeAlD
Olanzapine—ADRA2C—central nervous system—multiple sclerosis	0.000329	0.00161	CbGeAlD
Olanzapine—ADRA2A—spinal cord—multiple sclerosis	0.000324	0.00159	CbGeAlD
Olanzapine—ADRA2C—cerebellum—multiple sclerosis	0.000322	0.00158	CbGeAlD
Olanzapine—HTR2A—medulla oblongata—multiple sclerosis	0.000309	0.00151	CbGeAlD
Olanzapine—CHRM3—brain—multiple sclerosis	0.000299	0.00146	CbGeAlD
Olanzapine—HTR1A—brain—multiple sclerosis	0.000298	0.00146	CbGeAlD
Olanzapine—HTR7—brain—multiple sclerosis	0.000284	0.00139	CbGeAlD
Olanzapine—HTR2A—midbrain—multiple sclerosis	0.000282	0.00138	CbGeAlD
Olanzapine—ABCB1—retina—multiple sclerosis	0.00028	0.00137	CbGeAlD
Olanzapine—HRH1—nervous system—multiple sclerosis	0.000278	0.00136	CbGeAlD
Olanzapine—HTR2A—spinal cord—multiple sclerosis	0.000275	0.00135	CbGeAlD
Olanzapine—ADRA1A—brain—multiple sclerosis	0.000274	0.00134	CbGeAlD
Olanzapine—ADRA2A—nervous system—multiple sclerosis	0.000273	0.00134	CbGeAlD
Olanzapine—DRD2—brain—multiple sclerosis	0.000269	0.00132	CbGeAlD
Olanzapine—HRH1—central nervous system—multiple sclerosis	0.000268	0.00131	CbGeAlD
Olanzapine—ADRA2A—central nervous system—multiple sclerosis	0.000263	0.00129	CbGeAlD
Olanzapine—ADRA2C—brain—multiple sclerosis	0.000261	0.00128	CbGeAlD
Olanzapine—ADRA2A—cerebellum—multiple sclerosis	0.000257	0.00126	CbGeAlD
Olanzapine—HTR2A—nervous system—multiple sclerosis	0.000232	0.00114	CbGeAlD
Olanzapine—HTR2A—central nervous system—multiple sclerosis	0.000223	0.00109	CbGeAlD
Olanzapine—HTR2A—cerebellum—multiple sclerosis	0.000218	0.00107	CbGeAlD
Olanzapine—CYP3A4—nervous system—multiple sclerosis	0.000215	0.00105	CbGeAlD
Olanzapine—HRH1—brain—multiple sclerosis	0.000212	0.00104	CbGeAlD
Olanzapine—CYP2D6—nervous system—multiple sclerosis	0.000211	0.00103	CbGeAlD
Olanzapine—ADRA2A—brain—multiple sclerosis	0.000209	0.00102	CbGeAlD
Olanzapine—CYP3A4—central nervous system—multiple sclerosis	0.000207	0.00101	CbGeAlD
Olanzapine—CYP2D6—central nervous system—multiple sclerosis	0.000204	0.000996	CbGeAlD
Olanzapine—ABCB1—medulla oblongata—multiple sclerosis	0.000202	0.000991	CbGeAlD
Olanzapine—CYP2D6—cerebellum—multiple sclerosis	0.000199	0.000974	CbGeAlD
Olanzapine—ABCB1—midbrain—multiple sclerosis	0.000185	0.000905	CbGeAlD
Olanzapine—ABCB1—spinal cord—multiple sclerosis	0.00018	0.000883	CbGeAlD
Olanzapine—HTR2A—brain—multiple sclerosis	0.000177	0.000868	CbGeAlD
Olanzapine—CYP2D6—brain—multiple sclerosis	0.000162	0.000791	CbGeAlD
Olanzapine—ABCB1—nervous system—multiple sclerosis	0.000152	0.000744	CbGeAlD
Olanzapine—ABCB1—central nervous system—multiple sclerosis	0.000146	0.000717	CbGeAlD
Olanzapine—ABCB1—cerebellum—multiple sclerosis	0.000143	0.0007	CbGeAlD
Olanzapine—ABCB1—brain—multiple sclerosis	0.000116	0.000569	CbGeAlD
Olanzapine—HTR6—Signaling Pathways—MMP9—multiple sclerosis	7.14e-06	3.33e-05	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—MMP9—multiple sclerosis	7.13e-06	3.32e-05	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—IL2—multiple sclerosis	7.11e-06	3.32e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Metabolism—POMC—multiple sclerosis	7.1e-06	3.31e-05	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—MMP9—multiple sclerosis	7.08e-06	3.3e-05	CbGpPWpGaD
Olanzapine—CHRM4—Signaling by GPCR—IL6—multiple sclerosis	7.08e-06	3.3e-05	CbGpPWpGaD
Olanzapine—CHRM3—Metabolism—ALB—multiple sclerosis	7.05e-06	3.29e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—CCL2—multiple sclerosis	7.03e-06	3.28e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling by GPCR—MAPK1—multiple sclerosis	6.99e-06	3.26e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—CD80—multiple sclerosis	6.98e-06	3.25e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—TYK2—multiple sclerosis	6.95e-06	3.24e-05	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—MMP9—multiple sclerosis	6.93e-06	3.23e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—APOE—multiple sclerosis	6.91e-06	3.22e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling by GPCR—MAPK1—multiple sclerosis	6.88e-06	3.21e-05	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—IL2—multiple sclerosis	6.88e-06	3.21e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—CD80—multiple sclerosis	6.86e-06	3.2e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—CD80—multiple sclerosis	6.85e-06	3.19e-05	CbGpPWpGaD
Olanzapine—HTR2B—Signaling by GPCR—IL6—multiple sclerosis	6.85e-06	3.19e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—CD80—multiple sclerosis	6.83e-06	3.18e-05	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—MMP9—multiple sclerosis	6.82e-06	3.18e-05	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—IL2—multiple sclerosis	6.81e-06	3.18e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—CD80—multiple sclerosis	6.81e-06	3.17e-05	CbGpPWpGaD
Olanzapine—CHRM5—Signaling by GPCR—IL6—multiple sclerosis	6.78e-06	3.16e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—CD80—multiple sclerosis	6.74e-06	3.14e-05	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—MMP9—multiple sclerosis	6.73e-06	3.14e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—CD80—multiple sclerosis	6.72e-06	3.13e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—TYK2—multiple sclerosis	6.71e-06	3.13e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—TYK2—multiple sclerosis	6.67e-06	3.11e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—POMC—multiple sclerosis	6.63e-06	3.09e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—POMC—multiple sclerosis	6.52e-06	3.04e-05	CbGpPWpGaD
Olanzapine—ALB—Metabolism—APOE—multiple sclerosis	6.52e-06	3.04e-05	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—MMP9—multiple sclerosis	6.51e-06	3.04e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—POMC—multiple sclerosis	6.51e-06	3.04e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—TYK2—multiple sclerosis	6.49e-06	3.03e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—IL2—multiple sclerosis	6.49e-06	3.03e-05	CbGpPWpGaD
Olanzapine—HTR1E—Signaling Pathways—IL6—multiple sclerosis	6.49e-06	3.03e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—POMC—multiple sclerosis	6.49e-06	3.03e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—CCL2—multiple sclerosis	6.48e-06	3.02e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Metabolism—ALB—multiple sclerosis	6.47e-06	3.02e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—POMC—multiple sclerosis	6.47e-06	3.02e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling by GPCR—IL6—multiple sclerosis	6.46e-06	3.01e-05	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—MMP9—multiple sclerosis	6.45e-06	3.01e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—IL2—multiple sclerosis	6.4e-06	2.99e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—POMC—multiple sclerosis	6.4e-06	2.99e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—TYK2—multiple sclerosis	6.39e-06	2.98e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—POMC—multiple sclerosis	6.39e-06	2.98e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—CCL2—multiple sclerosis	6.38e-06	2.98e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling by GPCR—IL6—multiple sclerosis	6.37e-06	2.97e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—CCL2—multiple sclerosis	6.37e-06	2.97e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—CCL2—multiple sclerosis	6.35e-06	2.96e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling by GPCR—MAPK1—multiple sclerosis	6.34e-06	2.96e-05	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—STAT3—multiple sclerosis	6.34e-06	2.96e-05	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—STAT3—multiple sclerosis	6.34e-06	2.96e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—CCL2—multiple sclerosis	6.33e-06	2.95e-05	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—STAT3—multiple sclerosis	6.3e-06	2.94e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—CCL2—multiple sclerosis	6.27e-06	2.92e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—CCL2—multiple sclerosis	6.25e-06	2.91e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—CD80—multiple sclerosis	6.24e-06	2.91e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling by GPCR—MAPK1—multiple sclerosis	6.24e-06	2.91e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling by GPCR—MAPK1—multiple sclerosis	6.23e-06	2.91e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling by GPCR—MAPK1—multiple sclerosis	6.21e-06	2.9e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling by GPCR—MAPK1—multiple sclerosis	6.19e-06	2.89e-05	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—STAT3—multiple sclerosis	6.16e-06	2.88e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—MMP9—multiple sclerosis	6.14e-06	2.86e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling by GPCR—MAPK1—multiple sclerosis	6.13e-06	2.86e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling by GPCR—MAPK1—multiple sclerosis	6.11e-06	2.85e-05	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—STAT3—multiple sclerosis	6.07e-06	2.83e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—MMP9—multiple sclerosis	6.06e-06	2.83e-05	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—STAT3—multiple sclerosis	5.98e-06	2.79e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—POMC—multiple sclerosis	5.93e-06	2.77e-05	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—MYC—multiple sclerosis	5.9e-06	2.75e-05	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—MYC—multiple sclerosis	5.89e-06	2.75e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—TYK2—multiple sclerosis	5.89e-06	2.75e-05	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—TGFB1—multiple sclerosis	5.88e-06	2.74e-05	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—TGFB1—multiple sclerosis	5.87e-06	2.74e-05	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—APOE—multiple sclerosis	5.85e-06	2.73e-05	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—MYC—multiple sclerosis	5.85e-06	2.73e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—BCHE—multiple sclerosis	5.85e-06	2.73e-05	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—TGFB1—multiple sclerosis	5.84e-06	2.72e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—CCL2—multiple sclerosis	5.81e-06	2.71e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—TYK2—multiple sclerosis	5.79e-06	2.7e-05	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—STAT3—multiple sclerosis	5.79e-06	2.7e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—TYK2—multiple sclerosis	5.78e-06	2.7e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—IL2—multiple sclerosis	5.78e-06	2.7e-05	CbGpPWpGaD
Olanzapine—HRH2—Signaling Pathways—IL6—multiple sclerosis	5.78e-06	2.7e-05	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—MAPK1—multiple sclerosis	5.77e-06	2.69e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—TYK2—multiple sclerosis	5.76e-06	2.69e-05	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—MAPK1—multiple sclerosis	5.76e-06	2.69e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling by GPCR—IL6—multiple sclerosis	5.75e-06	2.68e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—TYK2—multiple sclerosis	5.74e-06	2.68e-05	CbGpPWpGaD
Olanzapine—DRD5—Signaling Pathways—IL6—multiple sclerosis	5.74e-06	2.68e-05	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—STAT3—multiple sclerosis	5.73e-06	2.67e-05	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—MYC—multiple sclerosis	5.73e-06	2.67e-05	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—MAPK1—multiple sclerosis	5.72e-06	2.67e-05	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—TGFB1—multiple sclerosis	5.71e-06	2.67e-05	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—APOE—multiple sclerosis	5.71e-06	2.66e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—TYK2—multiple sclerosis	5.69e-06	2.65e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling by GPCR—MAPK1—multiple sclerosis	5.68e-06	2.65e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—TYK2—multiple sclerosis	5.67e-06	2.65e-05	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—MYC—multiple sclerosis	5.64e-06	2.63e-05	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—TGFB1—multiple sclerosis	5.62e-06	2.62e-05	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—MAPK1—multiple sclerosis	5.6e-06	2.61e-05	CbGpPWpGaD
Olanzapine—ALB—Metabolism—POMC—multiple sclerosis	5.6e-06	2.61e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—IL2—multiple sclerosis	5.58e-06	2.6e-05	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—MYC—multiple sclerosis	5.56e-06	2.59e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling by GPCR—IL6—multiple sclerosis	5.55e-06	2.59e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—IL2—multiple sclerosis	5.55e-06	2.59e-05	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—TGFB1—multiple sclerosis	5.55e-06	2.59e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling by GPCR—IL6—multiple sclerosis	5.52e-06	2.58e-05	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—MAPK1—multiple sclerosis	5.51e-06	2.57e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—MMP9—multiple sclerosis	5.47e-06	2.55e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—STAT3—multiple sclerosis	5.46e-06	2.55e-05	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—MAPK1—multiple sclerosis	5.44e-06	2.54e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—IL2—multiple sclerosis	5.4e-06	2.52e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—STAT3—multiple sclerosis	5.39e-06	2.51e-05	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—APOE—multiple sclerosis	5.38e-06	2.51e-05	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—MYC—multiple sclerosis	5.38e-06	2.51e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling by GPCR—IL6—multiple sclerosis	5.37e-06	2.51e-05	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—TGFB1—multiple sclerosis	5.37e-06	2.5e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—APOE—multiple sclerosis	5.34e-06	2.49e-05	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—MYC—multiple sclerosis	5.33e-06	2.48e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—IL2—multiple sclerosis	5.31e-06	2.48e-05	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—TGFB1—multiple sclerosis	5.31e-06	2.48e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling by GPCR—IL6—multiple sclerosis	5.29e-06	2.47e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—MMP9—multiple sclerosis	5.28e-06	2.46e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—TYK2—multiple sclerosis	5.27e-06	2.46e-05	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—MAPK1—multiple sclerosis	5.26e-06	2.46e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—MMP9—multiple sclerosis	5.25e-06	2.45e-05	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—MAPK1—multiple sclerosis	5.21e-06	2.43e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—MMP9—multiple sclerosis	5.11e-06	2.38e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—MYC—multiple sclerosis	5.07e-06	2.37e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—TGFB1—multiple sclerosis	5.06e-06	2.36e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—MMP9—multiple sclerosis	5.03e-06	2.35e-05	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—POMC—multiple sclerosis	5.03e-06	2.34e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—MYC—multiple sclerosis	5.01e-06	2.34e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—TGFB1—multiple sclerosis	4.99e-06	2.33e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—MAPK1—multiple sclerosis	4.96e-06	2.32e-05	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—POMC—multiple sclerosis	4.91e-06	2.29e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—IL2—multiple sclerosis	4.9e-06	2.29e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—MAPK1—multiple sclerosis	4.9e-06	2.28e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling by GPCR—IL6—multiple sclerosis	4.88e-06	2.27e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—STAT3—multiple sclerosis	4.86e-06	2.27e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—IL2—multiple sclerosis	4.82e-06	2.25e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—IL2—multiple sclerosis	4.81e-06	2.24e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling by GPCR—IL6—multiple sclerosis	4.8e-06	2.24e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—IL2—multiple sclerosis	4.8e-06	2.24e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling by GPCR—IL6—multiple sclerosis	4.79e-06	2.23e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—IL2—multiple sclerosis	4.78e-06	2.23e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling by GPCR—IL6—multiple sclerosis	4.77e-06	2.23e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling by GPCR—IL6—multiple sclerosis	4.76e-06	2.22e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—IL2—multiple sclerosis	4.73e-06	2.21e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—IL2—multiple sclerosis	4.72e-06	2.2e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling by GPCR—IL6—multiple sclerosis	4.71e-06	2.2e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling by GPCR—IL6—multiple sclerosis	4.7e-06	2.19e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—STAT3—multiple sclerosis	4.7e-06	2.19e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—STAT3—multiple sclerosis	4.67e-06	2.18e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—MMP9—multiple sclerosis	4.64e-06	2.16e-05	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—POMC—multiple sclerosis	4.62e-06	2.16e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—POMC—multiple sclerosis	4.58e-06	2.14e-05	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—ALB—multiple sclerosis	4.58e-06	2.14e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—MMP9—multiple sclerosis	4.56e-06	2.13e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—APOE—multiple sclerosis	4.56e-06	2.13e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—MMP9—multiple sclerosis	4.55e-06	2.12e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—STAT3—multiple sclerosis	4.54e-06	2.12e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—MMP9—multiple sclerosis	4.54e-06	2.12e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—MMP9—multiple sclerosis	4.52e-06	2.11e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—MYC—multiple sclerosis	4.52e-06	2.11e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—TGFB1—multiple sclerosis	4.51e-06	2.1e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—MMP9—multiple sclerosis	4.48e-06	2.09e-05	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—ALB—multiple sclerosis	4.47e-06	2.09e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—STAT3—multiple sclerosis	4.47e-06	2.09e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—MMP9—multiple sclerosis	4.47e-06	2.08e-05	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—IL6—multiple sclerosis	4.43e-06	2.07e-05	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—IL6—multiple sclerosis	4.43e-06	2.06e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—MAPK1—multiple sclerosis	4.42e-06	2.06e-05	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—IL6—multiple sclerosis	4.4e-06	2.05e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—IL2—multiple sclerosis	4.39e-06	2.05e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling by GPCR—IL6—multiple sclerosis	4.36e-06	2.04e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—MYC—multiple sclerosis	4.36e-06	2.04e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—TGFB1—multiple sclerosis	4.35e-06	2.03e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—MYC—multiple sclerosis	4.34e-06	2.02e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—TGFB1—multiple sclerosis	4.33e-06	2.02e-05	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—IL6—multiple sclerosis	4.31e-06	2.01e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—MAPK1—multiple sclerosis	4.27e-06	1.99e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—MAPK1—multiple sclerosis	4.25e-06	1.98e-05	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—IL6—multiple sclerosis	4.24e-06	1.98e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—MYC—multiple sclerosis	4.22e-06	1.97e-05	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—ALB—multiple sclerosis	4.22e-06	1.97e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—TGFB1—multiple sclerosis	4.21e-06	1.96e-05	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—IL6—multiple sclerosis	4.18e-06	1.95e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—ALB—multiple sclerosis	4.18e-06	1.95e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—MYC—multiple sclerosis	4.16e-06	1.94e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—MMP9—multiple sclerosis	4.15e-06	1.94e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—TGFB1—multiple sclerosis	4.15e-06	1.93e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—MAPK1—multiple sclerosis	4.13e-06	1.93e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—STAT3—multiple sclerosis	4.12e-06	1.92e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—MAPK1—multiple sclerosis	4.07e-06	1.9e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—STAT3—multiple sclerosis	4.06e-06	1.89e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—STAT3—multiple sclerosis	4.05e-06	1.89e-05	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—IL6—multiple sclerosis	4.04e-06	1.89e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—STAT3—multiple sclerosis	4.04e-06	1.88e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—STAT3—multiple sclerosis	4.02e-06	1.88e-05	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—IL6—multiple sclerosis	4e-06	1.87e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—STAT3—multiple sclerosis	3.98e-06	1.86e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—STAT3—multiple sclerosis	3.97e-06	1.85e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—POMC—multiple sclerosis	3.92e-06	1.83e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—MYC—multiple sclerosis	3.83e-06	1.79e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—TGFB1—multiple sclerosis	3.82e-06	1.78e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—IL6—multiple sclerosis	3.81e-06	1.78e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—MYC—multiple sclerosis	3.77e-06	1.76e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—IL6—multiple sclerosis	3.76e-06	1.76e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—MYC—multiple sclerosis	3.76e-06	1.75e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—TGFB1—multiple sclerosis	3.76e-06	1.75e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—TGFB1—multiple sclerosis	3.75e-06	1.75e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—MYC—multiple sclerosis	3.75e-06	1.75e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—MAPK1—multiple sclerosis	3.75e-06	1.75e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—TGFB1—multiple sclerosis	3.74e-06	1.74e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—MYC—multiple sclerosis	3.74e-06	1.74e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—TGFB1—multiple sclerosis	3.73e-06	1.74e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—MYC—multiple sclerosis	3.7e-06	1.73e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—TGFB1—multiple sclerosis	3.69e-06	1.72e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—MYC—multiple sclerosis	3.69e-06	1.72e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—STAT3—multiple sclerosis	3.69e-06	1.72e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—MAPK1—multiple sclerosis	3.69e-06	1.72e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—TGFB1—multiple sclerosis	3.68e-06	1.72e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—MAPK1—multiple sclerosis	3.68e-06	1.72e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—MAPK1—multiple sclerosis	3.67e-06	1.71e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—MAPK1—multiple sclerosis	3.66e-06	1.71e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—MAPK1—multiple sclerosis	3.62e-06	1.69e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—MAPK1—multiple sclerosis	3.61e-06	1.68e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—ALB—multiple sclerosis	3.57e-06	1.67e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—APOE—multiple sclerosis	3.52e-06	1.64e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—MYC—multiple sclerosis	3.43e-06	1.6e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—TGFB1—multiple sclerosis	3.42e-06	1.6e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—IL6—multiple sclerosis	3.4e-06	1.58e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—MAPK1—multiple sclerosis	3.36e-06	1.57e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—IL6—multiple sclerosis	3.28e-06	1.53e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—IL6—multiple sclerosis	3.26e-06	1.52e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—IL6—multiple sclerosis	3.17e-06	1.48e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—IL6—multiple sclerosis	3.12e-06	1.46e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—POMC—multiple sclerosis	3.02e-06	1.41e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—IL6—multiple sclerosis	2.88e-06	1.34e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—IL6—multiple sclerosis	2.83e-06	1.32e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—IL6—multiple sclerosis	2.83e-06	1.32e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—IL6—multiple sclerosis	2.82e-06	1.31e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—IL6—multiple sclerosis	2.81e-06	1.31e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—IL6—multiple sclerosis	2.78e-06	1.3e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—IL6—multiple sclerosis	2.77e-06	1.29e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—ALB—multiple sclerosis	2.76e-06	1.29e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—IL6—multiple sclerosis	2.58e-06	1.2e-05	CbGpPWpGaD
